TP53 and neoplasm: PRIMA-1 is a low-molecular-weight compound discovered in 2002 after a molecular screening of a library of 2000 molecules from the National Cancer Institute that was performed to identify compounds that are able to restore the wild-type function of mut-p53 and suppress the growth of human tumor cells in a p53–dependent manner.